Ledger.Open graph →
SEC Form D · Amendment · filed October 22, 2025

Basking Biosciences, Inc

Offering
$55.0M
Sold
$55.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cary, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Steve Gillis · Chicago, ILDirectorAri Nowacek · Research Triangle Park, NCDirectorShahid Nimjee · Cary, NCDirectorThomas Needham · Concord, NHDirectorHannah Chang · SAN FRANCISCO, CADirectorJulia Owens · Ann Arbor, MIExec · Director · PromoterAiden Aceves · Del Mar, CADirectorDavid Adair · MORRISVILLE, NCDirectorHannah Chang · SAN FRANCISCO, CADirectorJulia Owens · Ann Arbor, MIExec · Director · PromoterAiden Aceves · Del Mar, CADirectorDavid Adair · St. Louis, MODirectorSteve Gillis · Chicago, ILDirectorAri Nowacek · Research Triangle Park, NCDirectorShahid Nimjee · Cary, NCDirectorThomas Needham · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗